| P50 | author | Asaff Harel | Q89483361 |
| P2093 | author name string | Sam Horng | |
| | Rebecca Straus Farber | |
| | Michelle Fabian | |
| | Tarah Gustafson | |
| | Anil Ramineni | |
| P2860 | cites work | Progressive multifocal leukoencephalopathy in patients with HIV infection | Q32073645 |
| | CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation | Q34118698 |
| | Nuclear phosphoinositide-specific phospholipase C β1 controls cytoplasmic CCL2 mRNA levels in HIV-1 gp120-stimulated primary human macrophages | Q34651978 |
| | Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy | Q34801893 |
| | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study | Q36041006 |
| | Interleukin-7 treatment of PML in a patient with idiopathic lymphocytopenia | Q36826947 |
| | CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals | Q37072697 |
| | Harnessing the biology of IL-7 for therapeutic application | Q37867487 |
| | Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia | Q38086994 |
| | Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1 | Q41741841 |
| | Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome | Q41906877 |
| | Treatment of progressive multifocal leukoencephalopathy with interleukin 7. | Q42208209 |
| | Progressive Multifocal Leukoencephalopathy | Q73239403 |
| | Long-term remission in progressive multifocal leukoencephalopathy caused by idiopathic CD4+ T lymphocytopenia: a case report | Q82703770 |
| | Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy | Q85290792 |
| | Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial | Q95823071 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| | progressive multifocal leukoencephalopathy | Q704930 |
| | idiopathic CD4 lymphocytopenia | Q55784739 |
| P304 | page(s) | 652-655 | |
| P577 | publication date | 2018-07-09 | |
| P1433 | published in | Journal of NeuroVirology | Q6295640 |
| P1476 | title | Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia | |
| P478 | volume | 24 | |